HIGHLIGHTS
- who: Siddhartha Goutam and collaborators from the Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T G , Canada have published the Article: Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with Ipilimumab, in the Journal: (JOURNAL) of 31/05/2020
- what: The aim of the study is to identify factors associated with long-term survival of three or more years in MM patients treated with anti-PD1 agents alone or in combination with ipilimumab. In this clinical series including both academic and community . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.